EPIRUS Biopharmaceuticals, Inc. Stock

Stocks

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

18-10-09	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-30	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI

18-10-09	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-30	Praxis Precision Medicines, Inc. completed the acquisition of Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q).	CI
18-01-19	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
18-01-17	Praxis Precision Medicines, Inc. agreed to acquire Z944 assets from EPIRUS Biopharmaceuticals, Inc. (OTCPK:EPRS.Q) for $1 million.	CI
17-12-11	Notice of Intent of Asset Sale Filed by EPIRUS Biopharmaceuticals, Inc.	CI
16-09-19	Motion for Asset Sale Approved for EPIRUS Biopharmaceuticals, Inc.	CI
16-08-05	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from S&P TMI Index	CI
16-08-03	EPIRUS Biopharmaceuticals, Inc.(OTCPK:EPRS.Q) dropped from NASDAQ Composite Index	CI
16-07-25	EPIRUS Biopharmaceuticals, Inc. Announces Management Resignations	CI
16-07-25	EPIRUS Biopharmaceuticals, Inc. Filed for Bankruptcy	CI
16-07-01	EPIRUS Biopharmaceuticals, Inc. Announces Executive Termination	CI
16-06-29	Polpharma S.A. completed the acquisition of EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc..	CI
16-06-13	Polpharma S.A. entered into a binding term sheet to acquire EPIRUS Biopharmaceuticals (Netherlands) B.V. from EPIRUS Biopharmaceuticals, Inc. for $3.5 million.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EPIRUS BIOPHARMACEUTICALS, INC.	-.--%	-.--%	-	-	26
WUXI APPTEC CO., LTD.	-0.70%	-4.28%	+52.62%	+86.42%	71.53B
ARGENX SE	-0.97%	+0.53%	+36.13%	+79.91%	60.12B
LONZA GROUP AG	-1.35%	+2.67%	+9.41%	+37.17%	48.85B
IQVIA HOLDINGS INC.	+0.58%	+1.00%	+42.43%	+39.53%	44.28B
REVOLUTION MEDICINES, INC.	+0.89%	+7.78%	+340.21%	+685.56%	43.83B
BEONE MEDICINES AG	+1.30%	+1.94%	+9.21%	+108.45%	41.53B
CELLTRION, INC.	+0.34%	+0.22%	+5.18%	+47.36%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+26.10%	27.98B
INSMED INCORPORATED	-1.35%	-3.24%	-20.49%	+351.32%	25.25B
Average	+0.37%	-0.05%	+56.83%	+162.43%	39.35B
Weighted average by Cap.	+0.15%	-0.16%	+61.59%	+152.81%